Outcomes of Pediatric Patients with Crohn’s Disease Received Infliximab or Exclusive Enteral Nutrition during Induction Remission

Figure 1

Comparisons of short-term disease outcomes among the two groups after induction remission therapy. (a) PCDAI scores and (c) CDIES scores of IFX- or EEN-treated patients at pre and postinduction therapy. Paired Student’s -test. Percentage of (b) IFX- or (d) EEN-treated patients in clinical remission () and endoscopic remission () after induction remission strategies. (e) BMIFA and (f) HFA of patients treated with EEN or IFX at diagnosis and at the end of induction therapy. Chi-squared or Fisher’s exact test. ; .

(a)

(b)

(c)

(d)

(e)

(f)